Evidence map›Paper›PMID 11567044›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2001

Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke.

N J Alkayed, S Goto, N Sugo, H D Joh, J Klaus, B J Crain, O Bernard, R J Traystman, P D Hurn

Open access · greenAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 3 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 3 syntheses or guidelines pooled it, 179 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Non-feminizing estrogens: a novel neuroprotective therapy.Molecular and cellular endocrinology · 2014
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

N J AlkayedDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. nalkayed@jhmi.edu
S Goto
N Sugo
H D Joh
J Klaus
B J Crain
O Bernard
R J Traystman
P D Hurn
Johns Hopkins Medicine · USWalter and Eliza Hall Institute of Medical Research · AU

Funding

Sigma Receptor Signaling in Focal IschemiaP01NS020020 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI HURN, PATRICIA D. · 1985 to 2007
$10.4M
Cerebral Ischemia in the Female and MaleR01NS033668 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI HURN, PATRICIA D. · 1995 to 2008
$2.5M
NINDS NIH HHS NS20020NINDS NIH HHS NS33668NINDS NIH HHS P01 NS020020NINDS NIH HHS R01 NS033668
6 · The paper itself

Abstract

Female rodents producing endogenous estrogens are protected from stroke damage in comparison with male counterparts. This natural protection is lost after ovariectomy or reproductive senescence. The aim of this study is to determine whether estrogen reduces early neuronal injury and cell loss after ischemia by increasing the expression of Bcl-2. Male, intact female, ovariectomized, and estrogen-repleted ovariectomized rats were subjected to middle cerebral artery occlusion, and 22 hr later the level and localization of Bcl-2 mRNA and protein were determined. The levels of post-ischemic bcl-2 mRNA and protein were increased exclusively in neurons within the peri-infarct region. Intact females and estrogen-treated castrates demonstrated increased bcl-2 mRNA and protein expression compared with males and estrogen-deficient females, accompanied by a decrease in infarct size. To test the hypothesis that the neuroprotective mechanism of estrogen functions via Bcl-2, we compared ischemic outcome in male, female, and ovariectomized wild-type mice and mice overexpressing Bcl-2 exclusively in neurons. Wild-type female mice sustained smaller infarcts compared with males. Bcl-2 overexpression reduced infarct size in males, but provided no added protection in the female. Moreover, ovariectomy exacerbated infarction in wild-type females, but had no effect in Bcl-2 overexpressors. These data indicate that overexpression of Bcl-2 simulates the protection against ischemic injury conferred by endogenous female sex steroids. We concluded that estrogen rescues neurons after focal cerebral ischemia by increasing the level of Bcl-2 in peri-infarct regions and that estrogen-induced bcl-2 gene expression is an important downstream component of neuronal protection in female stroke.

Indexed as

TransgenesAnimalsCell DeathCerebral InfarctionDisease SusceptibilityEstrogen Replacement TherapyEstrogensFemaleGene ExpressionGene Expression RegulationIn Situ HybridizationMaleMiceMice, Inbred C57BLMice, TransgenicNeuronsEstrogensProto-Oncogene Proteins c-bcl-2RNA, Messenger

Identifiers

PMID11567044
PMCPMC6762919
OpenAlexW2153146414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.